
AstraZeneca Drug Shows Promise for Rare Kidney Disease
A breakthrough treatment for a devastating rare kidney condition just moved closer to reality. AstraZeneca's Ultomiris has shown encouraging results in clinical trials, offering new hope to patients with limited options.




